OR WAIT null SECS
September 02, 2020
AstraZeneca has potentially taken poll position in the race to develop a novel coronavirus vaccine, but will AZD1222 be ready in 2020?
Amid high expectations for a vaccine, bio/pharma readies capacity, weighs pressures.
August 02, 2020
Time sure flies, except when you are waiting for something to happen.
COVID-19’s impact on the global economy is dealing a blow to merger and acquisition activity in the biopharma industry.
July 02, 2020
FDA Commissioner Hahn commits to a science-based review and approval process.
June 02, 2020
Achieving herd immunity will require testing, data, a vaccine, and public support.
May 02, 2020
Will moving at “warp speed” to develop a vaccine impact efficacy or safety?
April 02, 2020
As the coronavirus pandemic unfolds, Pharma must practice science over hype.
As COVID-19 rapidly spreads, the bio/pharma industry is committing significant efforts to fast track development of therapies.
March 02, 2020
Emergency action to protect patients and the drug supply may have long-term implications.